PU139
- CAS No.
- 158093-65-3
- Chemical Name:
- PU139
- Synonyms
- PU139;2-(4-Fluorophenyl)isothiazolo[5,4-b]pyridin-3(2H)-one;Isothiazolo[5,4-b]pyridin-3(2H)-one, 2-(4-fluorophenyl)-
- CBNumber:
- CB04718653
- Molecular Formula:
- C12H7FN2OS
- Molecular Weight:
- 246.26
- MDL Number:
- MOL File:
- 158093-65-3.mol
- MSDS File:
- SDS
- TDS File:
- TDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319 |
| Precautionary statements | P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330 |
PU139 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0087348 | PU139 99.51% | 158093-65-3 | 1mg | $77 | 2026-06-04 | Buy |
| ChemScene | CS-0087348 | PU139 99.51% | 158093-65-3 | 5mg | $162 | 2026-06-04 | Buy |
| ChemScene | CS-0087348 | PU139 99.51% | 158093-65-3 | 10mg | $282 | 2026-06-04 | Buy |
| ChemScene | CS-0087348 | PU139 99.51% | 158093-65-3 | 25mg | $536 | 2026-06-04 | Buy |
| ChemScene | CS-0087348 | PU139 99.51% | 158093-65-3 | 50mg | $747 | 2026-06-04 | Buy |
PU139 Chemical Properties, Uses, Production
Uses
PU139 is a potent pan-histone acetyltransferase (HAT) inhibitor. PU139 blocks the HATs Gcn5, p300/CBP-associated factor (PCAF), CREB (cAMP response element-binding) protein (CBP) and p300 with IC50s of 8.39, 9.74, 2.49 and 5.35 μM, respectively[1][2].
Biological Activity
PU139 is a potent pan-histone acetyltransferase (HAT) inhibitor. PU139 blocks the HATs Gcn5, p300/CBP-associated factor (PCAF), CREB (cAMP response element-binding) protein (CBP) and p300 with IC50s of 8.39, 9.74, 2.49 and 5.35 μM, respectively[1][2]. PU139 inhibits cell growth with GI50s of <60 μM (A431, A549, A2780, HepG2, SW480, U-87 MG, HCT116 and SK-N-SH and MCF7 cells)[1].PU139 (0-100 μM; 24-72 hours) triggers caspase-independent cell death in the neuroblastoma cell line SK-N-SH[1]. PU139 (25 mg/kg; i.p.) synergizes with Doxorubicin used as a prototypic chemotherapeutic drug in growth inhibition[1].
in vivo
PU139 (25 mg/kg; i.p.) synergizes with Doxorubicin used as a prototypic chemotherapeutic drug in growth inhibition[1].
| Animal Model: | Male NMRI:nu/nu mice (Neuroblastoma xenografts)[1] |
| Dosage: | 25 mg/kg |
| Administration: | Intraperitoneally (PU139) with Dxorubicin at 8mg/kg i.v.; Administered on days 14 and 21 as a single dose of each compound or, for combination therapy; both drugs were administered successively within 1h. |
| Result: | Optimum growth inhibition following a single PU139 therapy was moderate, but significant as compared with the untreated group and confirmed the previous findings. |
IC 50
GCN5: 8.39 μM (IC50); CREBBP: 2.49 μM (IC50); PCAF: 9.74 μM (IC50); p300: 5.35 μM (IC50)
References
[1]. Gajer JM, et al. Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo. Oncogenesis. 2015;4(2):e137. Published 2015 Feb 9. [2]. Carneiro VC, et al. Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasis. PLoS Pathog. 2014;10(5):e1004116. Published 2014 May 8.
PU139 Preparation Products And Raw materials
Raw materials
Preparation Products
PU139 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hangzhou Kaitan Technology Co., Ltd. | 18668996177 | 249358374@qq.com | China | 74 | 58 |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9799 | 58 |
| Shandong Lingqing Pharmaceutical Technology Co., Ltd. | 18668996177 | linkingpharm@126.com | China | 84 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6288 | 58 |
| Baimei Jihua (Henan) Pharmaceutical Technology Co., Ltd | 0371-88900765 18037465274 | 3430974218@qq.com | China | 14171 | 58 |
| Bide Pharmatech Ltd. | 400-1647117 13681763483 | product02@bidepharm.com | China | 59929 | 58 |
| Beijing Biocreative Technology Co., Ltd. | 15522676233 | 3007606172@qq.com | China | 1246 | 58 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24951 | 58 |
| Suzhou Zhixin Biotechnology Co., Ltd. | 0512-65118909 18100677375 | sales@szzxbio.com | China | 1057 | 58 |






